http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105988013-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e4f293ff92da9535f6b7f5164a053d4 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N35-00 |
| filingDate | 2015-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3818f8b861f9ca52aa10c61dbfd8f0d |
| publicationDate | 2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105988013-A |
| titleOfInvention | Liquid phase test chip |
| abstract | The invention discloses a liquid phase test chip. Point-of-care testing is a useful tool for solving the problems of insufficient medical resources and expensive health care or infectious disease spreading and chronic disease tracking or counting of adverse effects after medicine taking, the defects of inconvenience and high cost which are brought by the fact that in traditional testing, instruments are huge, and professionals need to participate in testing can be overcome through the fast-changing chip technology and the characteristics of being rapid and low in cost of the fast-changing chip technology, and great help is provided for disease screening and testing and disease condition tracking. The invention directly relates to a liquid phase test chip platform in order to meet the requirements of point-of-care testing. Different test methods can be applied on the platform to test different specific analytes in different tested bodies. The liquid phase test chip can be applied to the point-of-care testing application field. |
| priorityDate | 2015-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.